Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | Sinusoidal obstruction syndrome in patients with R/R B-cell ALL

Valentín Ortiz-Maldonado • 1 Sep 2020
EBMT 2020
Acute Lymphoblastic Leukemia Leukemia ARI-0001 CAR-T Inotuzumab ozogamicin

Valentín Ortiz-Maldonado, MD, Hospital Clínic de Barcelona, Barcelona, Spain, discusses sinusoidal obstruction syndrome in patients with relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (ALL) treated with ARI-0001 cells. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Valentín Ortiz-Maldonado

1:26
The major benefits of producing academic CAR T-cells
Valentín Ortiz-Maldonado • 10 Dec 2023
3:03
The impact of salvage and bridging therapy on CAR T-cell therapy outcomes in B-ALL: an ITT analysis
Valentín Ortiz-Maldonado • 10 Dec 2023
2:58
Var-cel shows promise for the treatment of CLL and Richter's transformation
Valentín Ortiz-Maldonado • 10 Dec 2023
2:25
Efficacy of varnimcabtagene autoleucel in patients with R/R BCL with no indication for CAR-T therapy
Valentín Ortiz-Maldonado • 8 Jun 2023

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals